These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31705966)
1. The multiple faces of tryptophan in bone biology. Al Saedi A; Sharma S; Summers MA; Nurgali K; Duque G Exp Gerontol; 2020 Jan; 129():110778. PubMed ID: 31705966 [TBL] [Abstract][Full Text] [Related]
2. New insights into tryptophan and its metabolites in the regulation of bone metabolism. Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827 [TBL] [Abstract][Full Text] [Related]
3. The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis. Vidal C; Li W; Santner-Nanan B; Lim CK; Guillemin GJ; Ball HJ; Hunt NH; Nanan R; Duque G Stem Cells; 2015 Jan; 33(1):111-21. PubMed ID: 25186311 [TBL] [Abstract][Full Text] [Related]
4. The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis. Ballesteros J; Rivas D; Duque G Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513550 [TBL] [Abstract][Full Text] [Related]
5. Picolinic Acid, a Catabolite of Tryptophan, Has an Anabolic Effect on Bone In Vivo. Duque G; Vidal C; Li W; Al Saedi A; Khalil M; Lim CK; Myers DE; Guillemin GJ J Bone Miner Res; 2020 Nov; 35(11):2275-2288. PubMed ID: 32629550 [TBL] [Abstract][Full Text] [Related]
6. [Enzymes of the kynurenine pathway]. Tankiewicz A; Pawlak D; Buczko W Postepy Hig Med Dosw; 2001; 55(5):715-31. PubMed ID: 11795205 [TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. Forrest CM; Mackay GM; Oxford L; Stoy N; Stone TW; Darlington LG Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1078-87. PubMed ID: 17042918 [TBL] [Abstract][Full Text] [Related]
8. The Role of Tryptophan Metabolites in Musculoskeletal Stem Cell Aging. Anaya JM; Bollag WB; Hamrick MW; Isales CM Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933099 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment. Pawlak K; Tankiewicz J; Mysliwiec M; Pawlak D Blood Coagul Fibrinolysis; 2009 Oct; 20(7):590-4. PubMed ID: 19491664 [TBL] [Abstract][Full Text] [Related]
10. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures. Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873 [TBL] [Abstract][Full Text] [Related]
11. Kynurenine suppresses osteoblastic cell energetics in vitro and osteoblast numbers in vivo. Pierce JL; Roberts RL; Yu K; Kendall RK; Kaiser H; Davis C; Johnson MH; Hill WD; Isales CM; Bollag WB; Hamrick MW; McGee-Lawrence ME Exp Gerontol; 2020 Feb; 130():110818. PubMed ID: 31862422 [TBL] [Abstract][Full Text] [Related]
12. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects. Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828 [TBL] [Abstract][Full Text] [Related]
13. Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats. Sibilia V; Pagani F; Dieci E; Mrak E; Marchese M; Zarattini G; Guidobono F Endocrine; 2013 Dec; 44(3):790-802. PubMed ID: 23619963 [TBL] [Abstract][Full Text] [Related]
14. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336 [TBL] [Abstract][Full Text] [Related]
15. Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study. Colle R; Masson P; Verstuyft C; Fève B; Werner E; Boursier-Neyret C; Walther B; David DJ; Boniface B; Falissard B; Chanson P; Corruble E; Becquemont L Psychiatry Clin Neurosci; 2020 Feb; 74(2):112-117. PubMed ID: 31599111 [TBL] [Abstract][Full Text] [Related]
16. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis? Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136 [TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. Fukui S; Schwarcz R; Rapoport SI; Takada Y; Smith QR J Neurochem; 1991 Jun; 56(6):2007-17. PubMed ID: 1827495 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Osteoporosis. Al Saedi A; Stupka N; Duque G Handb Exp Pharmacol; 2020; 262():353-367. PubMed ID: 32297003 [TBL] [Abstract][Full Text] [Related]
19. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890 [TBL] [Abstract][Full Text] [Related]
20. CK2.3, a Mimetic Peptide of the BMP Type I Receptor, Increases Activity in Osteoblasts over BMP2. Weidner H; Yuan Gao V; Dibert D; McTague S; Eskander M; Duncan R; Wang L; Nohe A Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]